Systematic analysis of the role of SLC52A2 in multiple human cancers

Table 2 The association between SLC52A2 expression and clincopathological features in LIHC

Clinical variables	No. of patients	SLC52A2 expression level		P value
Clinical variables	n = 40	Low (n = 20)	High (n = 20)	P value
Gender
Male	29	11	18	0.034
Female	11	9	2
Age (years)
< 60	31	18	13	0.130
≥ 60	9	2	7
HBsAg
Positive	36	18	18	1
Negative	4	2	2
AFP (ng/ml)
< 400	16	10	6	0.197
≥ 400	24	10	14
Liver cirrhosis
Yes	28	13	15	0.490
No	12	7	5
Child–Pugh Class
A	33	18	15	0.405
B	7	2	5
Tumor size (cm)
< 5 cm	13	10	3	0.043
≥ 5 cm	27	10	17
Vascular invasion
Yes	8	2	6	0.236
No	32	18	14
Tumor differentiation
Well	23	15	8	0.025
Poor	17	5	12
TNM stage
I–II	29	17	12	0.157
III–IV	11	3	8

ISSN: 1475-2867